accumulation and pathological
disease progression. Hence, epigenetic inhibition of pathologically activated
Erdman, V.V.,
Karimov, D.D.,
Tuktarova, I.A.,
Petintseva, A.A.,
Timasheva, Y.R.,
Nasibullin, T.R. (2025) of the SEMA6A (Yb8NBC597*ID, HR = 0.54, P = 0.016 for the cerebrovascular
diseases), TEAD1 (Ya5ac2013*II, HR
Mustafin, R.N.,
Bermisheva, M.A.,
Karunas, A.S.,
Akhmetshin, A.A.,
Monakhova, A.S.,
Khusnutdinova, E.K. (2025) the
disease. Materials and methods: clinical and epidemiological study of NF1 patients in the Republic